132 related articles for article (PubMed ID: 38729053)
1. Integrated transcriptome and metabolome study reveal the therapeutic effects of nicotinamide riboside and nicotinamide mononucleotide on nonalcoholic fatty liver disease.
Zhang J; Chen F
Biomed Pharmacother; 2024 Jun; 175():116701. PubMed ID: 38729053
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum-Mitochondria miscommunication in the liver of HFD mice.
Li Y; Tian X; Yu Q; Bao T; Dai C; Jiang L; Niu K; Yang J; Wang S; Wu X
Biomed Pharmacother; 2024 Jun; 175():116682. PubMed ID: 38703507
[TBL] [Abstract][Full Text] [Related]
4. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide Mononucleotide and Nicotinamide Riboside Reverse Ovarian Aging in Rats Via Rebalancing Mitochondrial Fission and Fusion Mechanisms.
Arslan NP; Taskin M; Keles ON
Pharm Res; 2024 May; 41(5):921-935. PubMed ID: 38684562
[TBL] [Abstract][Full Text] [Related]
6. Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
Rivera JC; Espinoza-Derout J; Hasan KM; Molina-Mancio J; Martínez J; Lao CJ; Lee ML; Lee DL; Wilson J; Sinha-Hikim AP; Friedman TC
Front Endocrinol (Lausanne); 2024; 15():1282231. PubMed ID: 38756999
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
8. NAD
Yoshino J; Baur JA; Imai SI
Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
[TBL] [Abstract][Full Text] [Related]
10. [The role of cytochrome P450 in nonalcoholic fatty liver induced by high-fat diet: a gene expression profile analysis].
Liu Y; Cheng F; Luo YX; Hu P; Ren H; Peng ML
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):285-290. PubMed ID: 28494548
[No Abstract] [Full Text] [Related]
11. Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
Salic K; Gart E; Seidel F; Verschuren L; Caspers M; van Duyvenvoorde W; Wong KE; Keijer J; Bobeldijk-Pastorova I; Wielinga PY; Kleemann R
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491949
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholyl Lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD.
Pathil A; Liebisch G; Okun JG; Chamulitrat W; Schmitz G; Stremmel W
Eur J Clin Invest; 2015 Sep; 45(9):925-31. PubMed ID: 26108973
[TBL] [Abstract][Full Text] [Related]
13. Ginger Essential Oil Ameliorates Hepatic Injury and Lipid Accumulation in High Fat Diet-Induced Nonalcoholic Fatty Liver Disease.
Lai YS; Lee WC; Lin YE; Ho CT; Lu KH; Lin SH; Panyod S; Chu YL; Sheen LY
J Agric Food Chem; 2016 Mar; 64(10):2062-71. PubMed ID: 26900108
[TBL] [Abstract][Full Text] [Related]
14. NAD
Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
[No Abstract] [Full Text] [Related]
15. A retinoic acid receptor β2 agonist attenuates transcriptome and metabolome changes underlying nonalcohol-associated fatty liver disease.
Tang XH; Melis M; Lu C; Rappa A; Zhang T; Jessurun J; Gross SS; Gudas LJ
J Biol Chem; 2021 Dec; 297(6):101331. PubMed ID: 34688661
[TBL] [Abstract][Full Text] [Related]
16. Nicotinamide mononucleotide production by fructophilic lactic acid bacteria.
Sugiyama K; Iijima K; Yoshino M; Dohra H; Tokimoto Y; Nishikawa K; Idogaki H; Yoshida N
Sci Rep; 2021 Apr; 11(1):7662. PubMed ID: 33828213
[TBL] [Abstract][Full Text] [Related]
17. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health.
Alegre GFS; Pastore GM
Curr Nutr Rep; 2023 Sep; 12(3):445-464. PubMed ID: 37273100
[TBL] [Abstract][Full Text] [Related]
18. Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers.
Uddin GM; Youngson NA; Chowdhury SS; Hagan C; Sinclair DA; Morris MJ
Cells; 2020 Mar; 9(4):. PubMed ID: 32218167
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced benefits on glucose handling in a model of diet-induced obesity are reduced by concurrent nicotinamide mononucleotide.
Yu J; Laybutt DR; Kim LJ; Quek LE; Wu LE; Morris MJ; Youngson NA
Am J Physiol Endocrinol Metab; 2021 Jul; 321(1):E176-E189. PubMed ID: 34121447
[TBL] [Abstract][Full Text] [Related]
20. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
